Home > Morphogenetic
Search results for: Morphogenetic
Error loading info... Pleas try again later.
#35971854 2022/08/16 To Up
Spatiotemporal DeliveryÂ ofÂ pBMP2Â andÂ pVEGFÂ byÂ aÂ Core-Sheath Structured Fiber-Hydrogel Gene-ActivatedÂ MatrixÂ Loaded withÂ Peptide-Modified NanoparticlesÂ forÂ Critical-sizedÂ BoneÂ Defect Repair.The clinical translation of bioactive scaffolds for the treatment of large segmental bone defects remains a grand challenge. The gene-activated matrix (GAM) combining gene therapy and tissue engineering scaffold offers a promising strategy for the restoration of structure and function of damaged or dysfunctional tissues. Herein, we have developed a gene-activated biomimetic composite scaffold consisting of an electrospun poly(Îµ-caprolactone) (PCL) fiber sheath and an alginate hydrogel core which carried plasmid DNA encoding bone morphogenetic protein 2 (pBMP2) and vascular endothelial growth factor (pVEGF), respectively. A peptide-modified polymeric nanocarrier with low cytotoxicity and high efficiency serves as the non-viral DNA delivery vector. The obtained GAM allows spatiotemporal release of pVEGF and pBMP2 and promotes osteogenic differentiation of pre-osteoblasts in vitro. In vivo evaluation using a critical-sized segmental femoral defect model in rats shows that the dual gene delivery system can significantly accelerate bone healing by activating angiogenesis and osteogenesis. These findings demonstrate the effectiveness of the developed dual gene-activated core-sheath structured fiber-hydrogel composite scaffold for critical-sized bone defect regeneration and the potential of cell-free scaffold-based gene therapy for tissue engineering. This article is protected by copyright. All rights reserved.
Shan He, Ju Fang, Chuanxin Zhong, Min Wang, Fuzeng Ren